Allergen (AGN)/Pfizer (PFE) Deal Creates Mid-Teens Synergies in Year 2 - RBC Capital

Allergen (AGN) Should Buy Pfizer (PFE), Not the Other Way Around - Analyst

Recent news points to Pfizer (NYSE: PFE) in preliminary talks to acquire Allergen (NYSE: AGN). However, according to one analyst, the deal should be the other way around.

Nomura Securities analyst Shibani Malhotra said Allergen... More

Pfizer (PFE) Confirms Discussions with Allergan (AGN)

Pfizer (NYSE: PFE) notes the announcement by Allergan (NYSE: AGN) that was released earlier today regarding a potential transaction between the companies. Pfizer confirms that it is in preliminary friendly discussions with Allergan in relation to a potential... More

Pfizer (PFE) Offering $375 - $400/Share for Allergan (AGN) Might Seal Deal - Leerink

Leerink is out with commentary on Allergan (NYSE: AGN) following news that it and Pfizer (NYSE: PFE) are in talks over a potential deal.

Analyst Jason Gerberry is updating his Pfizer-Allergan model, which assumes at $375 per Allergan share takeover price. The analyst commented:

Following recent speculation that PFE (MP) and AGN are in discussions around a potential merger, we weigh in on (1) price; (2) people factor; (3) AGN M&A... More

Potential Allergan (AGN), Pfizer (PFE) Tie-Up No Surprise But May Take $400 to Get Done

Following an eye-opening report late Wednesday from the WSJ, Allergan (NYSE: AGN) confirmed this morning that it has been... More

Pre-Open Stock Movers 10/29: (LOCK) (HBI) (AGN) Higher; (STRP) (AFOP) (NXPI) Lower (more...)

Revance Therapeutics (Nasdaq: RVNC) 40.3% HIGHER; announced positive 24-week results today from its multi-center BELMONT Phase 2 active comparator study of injectable RT002. The ongoing study for the treatment of glabellar lines in 268 subjects compared the safety,... More

Allergan (AGN) Affirms Talks with Pfizer (PFE)

Allergan (NYSE: AGN) confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction. Allergan stated that no agreement has been reached and there can be no certainty that these discussions... More

Pfizer (PFE), Allergan (AGN) in Talks About Blockbuster Deal - WSJ

Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) are considering a merger the Wall Street Journal reported late Wednesday, citing people familiar with the matter.

Pfizer has approached Allergan about a... More